Rui Tostoes, Chief Technology Officer at ImmuneBridge, shares how his team is redefining preclinical development and ...

A team of scientists from the San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget) in Milan, Italy, has identified a ...

Children born before 37 weeks of gestation have a considerably increased risk of dying before they reach the age of five.

The variety of blood cells decreases with age. Some are lost, while others become dominant, leading to a loss of functional ...

The aging of the innermost cell layer of blood vessels leads to cardiovascular diseases. Researchers at UZH have now shown ...

Banking a baby’s umbilical cord blood was once seen as a reasonable way to protect their future health, but much of that ...

Miniature organs on a chip could allow us to do scientific studies with great precision, without having to resort to animal testing. The main problem, however, is that artificial tissue needs blood ...

At last, the stage was set for lifesaving blood transfusions. No more lambs’ or calves’ blood; no more transfusions from ...

Manufacturing CAR T cells in the laboratory is expensive and time-consuming. An in vivo approach could get the powerful ...

A decades-old TB vaccine turned cancer therapy may unlock new immunotherapies by reprogramming immune cell development in the ...

Targeted deletion of integrin-associated protein CD47 enhances long-term engraftment of human CD34 + cells in immunodeficient pigs lacking IL2RG and RAG2, enabling large-scale production of ...

A study uncovers that crab immune cells can transform into neural cells, enhancing our understanding of how crustaceans ...